PART IV: Mifepristone lawsuit
The FDA should win this case hands down. They’ve got all the safety and effectiveness data on their side. They might not even have to prove anything in court with the case being dismissed by SCOTUS on the basis of standing and or merit.
The FDA should win this case hands down. They’ve got all the safety and effectiveness data on their side. They might not even have to prove anything in court with the case being dismissed by SCOTUS on the basis of standing and or merit.